BIO-TECHNE CORP. DL-,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of TE1 for the last quarter is 281.21 M EUR, and it's 13.86% higher compared to the previous quarter. The net income of Q3 24 is 45.46 M EUR.